EMA mAb Workshop – Quality Target Product Profile in the Development of a Biosimilar

Related Posts

• EMA mAb Workshop – Stepwise Approach to Non-Clinical… 31 October 2013
• EMA mAb Workshop – Guideline on Similar Biological… 31 October 2013
• Shaping The 2020 Regulatory Landscape For Patient Needs 28 January 2016 London - 61 regulators from 25 countries made progress in improving the…
• The European Biosimilars Group Appoints New Leadership Team… 10 February 2016 Last week in Brussels, the European Biosimilar medicines Group (EBG…